Evidence map›Paper›PMID 29204282›Full record

ArticleNew microbes and new infections2018

E Ruppé, A Cherkaoui, N Wagner, G C La Scala, J-Y Beaulieu, M Girard, J Frey, V Lazarevic, J Schrenzel

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in New microbes and new infections, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. A Retrospective Analysis ofMicroorganisms · 2024
    Article
  3. Article
  4. Medicinal Leech Therapy in Urology: A PRISMA-Compliant Systematic Review.African journal of urology : the official journal of the Pan African Urological Surgeons' Association (PAUSA) · 2023
    Article
  5. Article
  6. Article
  7. Epidemiology of β-Lactamase-Producing Pathogens.Clinical microbiology reviews · 2020
    Review
  8. A MesophilicMicroorganisms · 2019
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

E RuppéGenomic Research Laboratory, Division of Infectious Diseases, Switzerland.
A CherkaouiBacteriology Laboratory, Division of Laboratory Medicine, Department of Genetics and Laboratory Medicine, Switzerland.
N WagnerPediatric Infectious Diseases, Department of Pediatrics, Switzerland.
G C La ScalaDivision of Pediatric Surgery, Department of Pediatrics, Switzerland.
J-Y BeaulieuHand Surgery Unit, Division of Orthopedic Surgery, Department of Surgery, Geneva University Hospitals, Geneva, Switzerland.
M GirardGenomic Research Laboratory, Division of Infectious Diseases, Switzerland.
J FreyInstitute of Veterinary Bacteriology, University of Bern, Bern, Switzerland.
V LazarevicGenomic Research Laboratory, Division of Infectious Diseases, Switzerland.
J SchrenzelGenomic Research Laboratory, Division of Infectious Diseases, Switzerland.
University Hospital of Geneva · CHUniversity of Bern · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report the selection in a 15-year-old boy of a multidrug-resistant, extended-spectrum β-lactamase (ESBL)-producing

Indexed as

Aeromonas salmonicidamedicinal leech therapymultidrug resistancewhole genome sequencing

Identifiers

PMID29204282
PMCPMC5709350
OpenAlexW2761194402

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.